These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 22213868)
1. [Efficacy of voriconazole for treatment of invasive fungal infections in 87 cases with hematologic malignancies]. Feng AM; Wei JY; Yu WJ Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):473-5. PubMed ID: 22213868 [No Abstract] [Full Text] [Related]
2. [Outcome analysis of caspofungin in combination with voriconazole for treatment of 12 hematologic malignancies cases with invasive fungal infection]. Sun HL; Zhou X; Shen YF Zhonghua Xue Ye Xue Za Zhi; 2011 Aug; 32(8):558-9. PubMed ID: 22338183 [No Abstract] [Full Text] [Related]
3. Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy. Baden LR; Katz JT; Fishman JA; Koziol C; DelVecchio A; Doran M; Rubin RH Transplantation; 2003 Dec; 76(11):1632-7. PubMed ID: 14702539 [TBL] [Abstract][Full Text] [Related]
4. Case collection study of the safety of AmBisome in association with voriconazole in the treatment of patients with invasive fungal infection. Askari E; Jarque I; Nicolás Franco S; Cáceres Agra JJ Rev Esp Quimioter; 2010 Dec; 23(4):210-2. PubMed ID: 21191561 [No Abstract] [Full Text] [Related]
5. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain]. Díaz Pedroche C; Cisneros JM; Lumbreras C; Aguado JM; Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037 [TBL] [Abstract][Full Text] [Related]
6. Antifungal therapy in patients with hematological malignancies: how to avoid overtreatment? Cherif H; Kalin M; Björkholm M Eur J Haematol; 2006 Oct; 77(4):288-92. PubMed ID: 16856930 [TBL] [Abstract][Full Text] [Related]
7. Oral voriconazole for empiric antifungal treatment in patients with uncomplicated febrile neutropenia. Przepiorka D; Buadi FK; McClune B Pharmacotherapy; 2008 Jan; 28(1):58-63. PubMed ID: 18154475 [TBL] [Abstract][Full Text] [Related]
8. Voriconazole: a broad-spectrum triazole for the treatment of invasive fungal infections. Cecil JA; Wenzel RP Expert Rev Hematol; 2009 Jun; 2(3):237-54. PubMed ID: 21082966 [TBL] [Abstract][Full Text] [Related]
9. Candida krusei arthritis in a patient with hematologic malignancy: successful treatment with voriconazole. Sili U; Yilmaz M; Ferhanoglu B; Mert A Clin Infect Dis; 2007 Oct; 45(7):897-8. PubMed ID: 17806057 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and therapeutic analysis of invasive fungal infection in chronic severe hepatitis patients. Hou Z; Tan D; Liu G; Xie Y; Li C; Xie J; Lu M; Liu Z; Sha X Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Jun; 35(6):537-42. PubMed ID: 20622324 [TBL] [Abstract][Full Text] [Related]
11. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Perfect JR; Marr KA; Walsh TJ; Greenberg RN; DuPont B; de la Torre-Cisneros J; Just-Nübling G; Schlamm HT; Lutsar I; Espinel-Ingroff A; Johnson E Clin Infect Dis; 2003 May; 36(9):1122-31. PubMed ID: 12715306 [TBL] [Abstract][Full Text] [Related]
13. Improving outcomes of acute invasive Aspergillus rhinosinusitis in patients with hematologic malignancies or aplastic anemia: the role of voriconazole. Girmenia C; Pizzarelli G; Pozzi E; Cimino G; Gentile G; Martino P Haematologica; 2008 Jan; 93(1):159-60. PubMed ID: 18166809 [TBL] [Abstract][Full Text] [Related]
14. [Voriconazole: a new weapon against invasive fungal infections]. Aoun M Rev Med Brux; 2004 Jun; 25(3):166-71. PubMed ID: 15291449 [TBL] [Abstract][Full Text] [Related]
15. Voriconazole concentrations and outcome of invasive fungal infections. Miyakis S; van Hal SJ; Ray J; Marriott D Clin Microbiol Infect; 2010 Jul; 16(7):927-33. PubMed ID: 19845698 [TBL] [Abstract][Full Text] [Related]
16. Fusarium peritonitis concomitant to kidney transplantation successfully managed with voriconazole: case report and review of the literature. Garbino J; Uckay I; Rohner P; Lew D; Van Delden C Transpl Int; 2005 May; 18(5):613-8. PubMed ID: 15819812 [TBL] [Abstract][Full Text] [Related]
17. The emerging life-threatening opportunistic fungal pathogen Kodamaea ohmeri: optimal treatment and literature review. Shang ST; Lin JC; Ho SJ; Yang YS; Chang FY; Wang NC J Microbiol Immunol Infect; 2010 Jun; 43(3):200-6. PubMed ID: 21291847 [TBL] [Abstract][Full Text] [Related]
18. Use of voriconazole to successfully treat disseminated Trichosporon asahii infection in a patient with acute myeloid leukaemia. Fournier S; Pavageau W; Feuillhade M; Deplus S; Zagdanski AM; Verola O; Dombret H; Molina JM Eur J Clin Microbiol Infect Dis; 2002 Dec; 21(12):892-6. PubMed ID: 12525928 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal voriconazole for drug-resistant fungal endophthalmitis: case series. Sen P; Gopal L; Sen PR Retina; 2006 Oct; 26(8):935-9. PubMed ID: 17031296 [TBL] [Abstract][Full Text] [Related]
20. Topical and oral voriconazole in the treatment of fungal keratitis. Bunya VY; Hammersmith KM; Rapuano CJ; Ayres BD; Cohen EJ Am J Ophthalmol; 2007 Jan; 143(1):151-3. PubMed ID: 17188052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]